Melredableukin alfa

N/A

Report date: 2024/07/05 20:00:49

Base Information

Drug NameMelredableukin alfa
Drug Alias NameRO-7049665IgG-IL2-FPMelredableukin alphaMelredableukin αRG-7835 +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-2 receptor antagonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsHepatitis, AutoimmuneColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUkraine +[13] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis, AutoimmuneColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A